Introduction
Endometrial cancer (EC) is the most common gynecologic cancer in the United States, with over 46,470 new cases expected in 2012.(1) Risk factors for EC include early age at menarche, nulliparity, menopause and obesity. Obese women have up to 9 times the risk of developing EC as their normalweight counterparts, (2, 3) and obesity is also the most potentially modifiable risk factor for EC. (4) The mechanism by which obesity may increase cancer risk is by increasing circulating levels of estrone, which leads to excess estrogen, increases the mitotic activity of endometrial cells, and promotes cellular replication that leads to hyperplasia and carcinoma. (5) Past studies have shown that women with higher levels of obesity tend to have less aggressive disease stage and histology of EC. (3, (6) (7) (8) which is due to a higher incidence of better-differentiated, less invasive adenocarcinomas with less frequent lymph node metastases. Others have observed that the relationship between obesity and EC may be confounded by other factors, such as tumor grade, age and race. Temkin et al. found that BMI was not an independent risk factor for EC survival, and that the apparent protective effect of obesity on survival was due to obese subjects being younger, and having lower grade and earlier stage tumors.(3) While most studies have examined the effect of obesity on EC survival, associations between obesity and EC stage, as well as the effect of other risk factors, have not been well-documented. (6, 10) Diet and physical activity, especially diets consisting of high fat, high glycemic load, and low fruit/vegetable consumption, as well as low levels of physical activity, have also shown associations with increased EC risk, but no documented associations have been found with EC stage. (11) (12) (13) (14) Since earlier stage EC normally has better prognosis, it is especially important to identify modifiable risk factors that are associated with late versus early stage disease. Fader et al. confirmed the importance of examining modifiable risk factors, especially the effect of healthier lifestyles, with regard to EC outcomes. (15) The purpose of this study was to further investigate the association between obesity and other risk factors on EC stage at diagnosis. The effect of both non-modifiable risk factors, such as age, race and grade, and modifiable lifestyle factors, such as diet (fat, fruit/vegetable consumption, and glycemic load) and physical activity expenditure, were examined in relation to severe obesity and late versus early stage at EC diagnosis.
Methods

Study Design/Participants
Women from 3 hospitals (The Ohio State University (OSU), Walter Reed Army Medical Center, and Duke University Medical Center) who were diagnosed with EC were asked to consent to this study during their pre-operative visit with a gynecologic oncologist. Criteria for inclusion in this study were: age >18 years, histologically confirmed EC diagnosis, and literacy in English. Women were asked to complete the questionnaires prior to surgery. Out of 208 women who were eligible to participate in this study, 177 women agreed to provide consent, resulting in a response rate of 85%. This study was . Due to small strata, BMI was dichotomized using the median (BMI<35=0 versus >35=1), which is defined as Class II/severe obesity.(19) Age was also dichotomized in this analysis using the median (age<60=0 versus >60=1). Race was assessed as white=1 versus non-white=0. Grade was dichotomized using the FIGO classifications (well or moderately differentiated=0 versus poorly differentiated=1), with the categories combined due to small strata. Lifestyle variables included total calories, fruits and vegetables consumed per day, total grams of carbohydrate, fat and fiber consumed per day, glycemic load, and total energy expenditure (metabolic equivalents, or METs), which were also dichotomized based on their median values. Log transformations were performed on highly skewed variables. Women whose cancer stage and grade were missing or could not be assessed were excluded from the analyses (n=3 and 5, respectively), resulting in data from 169 women available for this analysis.
Univariate logistic regression analyses were first conducted between obesity and risk factors related to EC stage at diagnosis. Using forward selection, the variables were added to a multivariable model by selecting the variables with the lowest p-value until the p-value was no longer significant (alpha=0.05). Analyses were conducted using Stata 10. (20) Results Table 1 displays the descriptive characteristics of women by EC stage. Overall, 68% of women had a BMI>30, which is considered obese, and half the women were severely obese (median BMI=35).
Women diagnosed at late versus early EC stage were older (median=63 and 58 years, respectively), were less likely to be severely obese (BMI>35; 40% and 55% kg/m 2 , respectively), and were more likely to have poorly differentiated tumors (39% versus 9%, respectively; p<0.0001). The mean calorie intake and METs were 1561 and 8, respectively, with no significant differences in diet and physical activity variables by EC stage at diagnosis. 
Grade and age were assessed for possible interactions with BMI, but neither was significant.
The multivariate model ( Diet and physical activity variables showed no significant associations with EC stage at diagnosis in this study, although the groups differed significantly with respect to several dietary and physical activity factors, such as increased caloric and fat intake, along with decreased physical activity levels among severely obese women, which was expected. The diets of women in this study were also relatively high in glycemic load, which has shown associations with increased EC risk in past studies. (12) Many participants also reported low overall levels of energy expenditure from recreational physical activity in this study, which has also shown increased EC risk. (13) Due to inconsistent results in the obesity-EC association among researchers, as previously indicated, further studies are warranted since this information can be useful in the management and treatment of EC in obese women. (3, 7, 9) For example, obese patients have been shown to be less likely to undergo lymph node evaluation than ideal body weight women due to a less aggressive disease stage and histology in obese women, as well as increased difficulty reported in performing lymph node dissection. (7) However, it was concluded that performing adequate lymphadenectomy is important for obese women who are in earlier EC stage, since their risk of extrauterine disease, including lymph node metastases, can be similar to that of ideal weight women. (7, 8) Strengths of this study include that it examined a population of women with severe versus nonsevere BMI, who had histologically confirmed endometrial cancer from 3 diverse sites in the United
States. Demographic and anthropometric data were obtained from perioperative clinic data versus selfreport; only diet and physical activity data were self-reported. Trained study staff ensured uniformity of data collection and consistent reporting procedures across sites. 
Limitations of this study include its cross-sectional design, which the limited ability to make causal inferences, and the fact that we were not able to assess survival. Misclassification of diet and physical activity variables could have occurred since those surveys were based on participant recall. The low reported mean caloric intake (1561 calories) may have been underestimated, which is a common problem with FFQs. (24) 
